John Tamerius

John Tamerius, Ph.D. has extensive work experience in the biotechnology and healthcare industry. John started their career at Cytotech, Inc. in 1983, where they served as the Sr. Vice President for Research and Development. During their time there, they contributed to the development and clearance of nine FDA-approved products and over 70 research reagents, with a focus on the human complement system. In 1989, Cytotech, Inc. was acquired by Quidel Corporation, and John transitioned to the role of Sr. Vice President for Clinical and Regulatory Affairs. At Quidel, they played a crucial role in the development, manufacture, and global marketing of rapid diagnostic tests for physician offices and acute care settings, particularly under the QuickVue brand.

From 1963 to 1976, John Tamerius attended the University of Washington. No specific degree or field of study was provided.